Novartis Delivered High Single-Digit Sales Growth, Achieved 40% Core Margin and Further Advanced the Pipeline in 2025
February 06, 2026
February 06, 2026
BASEL, Switzerland, Feb. 6 -- Novartis, a pharmaceutical company, issued the following news release:
* * *
Novartis delivered high single-digit sales growth, achieved 40% core margin and further advanced the pipeline in 2025
Ad hoc announcement pursuant to Art. 53 LR
Full year
* Net sales grew +8% (cc1, +8% USD) with core operating income1 up +14% (cc, +12% USD)
- Sales growth driven by continued strong performance fro . . .
* * *
Novartis delivered high single-digit sales growth, achieved 40% core margin and further advanced the pipeline in 2025
Ad hoc announcement pursuant to Art. 53 LR
Full year
* Net sales grew +8% (cc1, +8% USD) with core operating income1 up +14% (cc, +12% USD)
- Sales growth driven by continued strong performance fro . . .
